A company’s scientific evidence is one of its most valuable strategic resources.

Evidence is both the language and currency of life science organisations as it underpins the full spectrum of therapeutic business activities from product development to product registration, pricing, marketing and sales.

The quality of published papers can vary widely and the evidence constantly changes as new products, new claims or new treatment regimes and standards are introduced.  The demands on evidence are dynamic and can change as new products, new claims and local market regulations or treatment regimes vary. 

To be most effective in their respective job functions, pharmaceutical professionals need to be competent at interpreting and communicating the evidence. This requires organisations to be scientifically strong and effective at converting and communicating that evidence into commercial benefit.

For various departments or business situations, this may translate differently; for example:

• For sales representatives having the confidence in discussing the evidence and having a deeper understanding of the evidence to assist in building a more complete or meaningful relationship with their clients.
  
  
• For marketing and medical affairs personnel discussing the evidence in support of product claims, a deeper understanding of good evidential practice may assist in more productive dialogue and superior business outcomes.
  
  
• For training and HR managers involved in recruitment providing an objective assessment methodology to assist in candidate selection and determining new candidate future training requirements.